Acrongenomics Inc. is a publicly traded company that focuses on
investing in and commercializing novel technology platforms
concerning the Life Sciences sector.
Acrongenomics brings novel and realistic concepts to market by
transforming scientific innovations into tangible,
consumer-orientated applications. The company has its headquarters
in Geneva, Switzerland.